According to a new report published by OG Analysis, the global Head and Neck Cancer Diagnostics Market was valued at USD 6.51 billion in 2026 and is projected to reach USD 15.23 billion by 2034, expanding at a CAGR of 11.2% during the forecast period. Market Overview The market spans imaging modalities, endoscopic systems, biopsy and histopathology services, immunohistochemistry assays, viral...